Global Pharmaceutical Regulatory Affairs Summit
Informa Life Sciences’ Global Pharmaceutical Regulatory Affairs Summit, taking place on 27th – 29th October 2015 in Berlin, Germany, combines…
Informa Life Sciences’ Global Pharmaceutical Regulatory Affairs Summit, taking place on 27th – 29th October 2015 in Berlin, Germany, combines…
Private healthcare markets in Central Europe are still young markets replete with opportunities. There is substantial demand for such services…
The European Medicines Agency (EMA) has released a list of standardized terms describing medical events it says will be used…
The government has allocated around 235 billion forints (EUR 754.6m) towards the first phase of hospital development and upgrades planned…
Based on the WHO definition pharmacovigilance is “scientific research related to the detection, assessment, understanding and prevention of adverse reactions…
Belarus: Decree no 228 of 21 June 2016 establishes new rules for pricing of pharmaceuticals, medical devices and medical equipment (“medical…
Sales of mid- and high-priced drugs in Russia are steadily declining, due to the ongoing economic stagnation in the country…
Prague, 20 June 1016 – The Prague office of Baker & McKenzie recently hosted the latest in a series of…
Patients and clinicians need greater regulatory transparency to make informed decisions about treatment. Medical devices approved first in the European…
The PSUR repository is a single, central platform for PSURs and related documents to be used by all regulatory authorities…